Header Logo

Connection

Zoe Arvanitakis to Humans

Back to Details
This is a "connection" page, showing publications Zoe Arvanitakis has written about Humans.
Zoe Arvanitakis
Connection Strength
1.642
Humans
  1. Metformin, age-related cognitive decline, and brain pathology. Neurobiol Aging. 2024 Jan; 133:99-106.
    View in: PubMed
    Score: 0.051
  2. Insulin resistance, cognition, and Alzheimer disease. Obesity (Silver Spring). 2023 06; 31(6):1486-1498.
    View in: PubMed
    Score: 0.050
  3. Genome-Wide Mapping Implicates 5-Hydroxymethylcytosines in Diabetes Mellitus and Alzheimer's Disease. J Alzheimers Dis. 2023; 93(3):1135-1151.
    View in: PubMed
    Score: 0.049
  4. Derivation and validation of the Rapid Assessment of Dementia Risk (RADaR) for older adults. PLoS One. 2022; 17(3):e0265379.
    View in: PubMed
    Score: 0.046
  5. Brain insulin signaling and cerebrovascular disease in human postmortem brain. Acta Neuropathol Commun. 2021 04 15; 9(1):71.
    View in: PubMed
    Score: 0.043
  6. The Relation of Diabetes to Memory Function. Curr Neurol Neurosci Rep. 2020 11 05; 20(12):64.
    View in: PubMed
    Score: 0.042
  7. Brain Insulin Signaling, Alzheimer Disease Pathology, and Cognitive Function. Ann Neurol. 2020 09; 88(3):513-525.
    View in: PubMed
    Score: 0.041
  8. Association of Low Systolic Blood Pressure with Postmortem Amyloid-? and Tau. J Alzheimers Dis. 2020; 78(4):1755-1764.
    View in: PubMed
    Score: 0.039
  9. What Is Dementia? JAMA. 2019 11 05; 322(17):1728.
    View in: PubMed
    Score: 0.039
  10. Diagnosis and Management of Dementia: Review. JAMA. 2019 10 22; 322(16):1589-1599.
    View in: PubMed
    Score: 0.039
  11. Insulin and adipokine signaling and their cross-regulation in postmortem human brain. Neurobiol Aging. 2019 12; 84:119-130.
    View in: PubMed
    Score: 0.038
  12. Diabetes Therapies for Dementia. Curr Neurol Neurosci Rep. 2019 07 12; 19(8):58.
    View in: PubMed
    Score: 0.038
  13. Antiphospholipid Antibodies: Cognitive and Motor Decline, Neuroimaging and Neuropathology. Neuroepidemiology. 2019; 53(1-2):100-107.
    View in: PubMed
    Score: 0.038
  14. Author response: Late-life blood pressure association with cerebrovascular and Alzheimer disease pathology. Neurology. 2019 04 09; 92(15):732.
    View in: PubMed
    Score: 0.038
  15. Brain IGFBP-5 modifies the relation of depressive symptoms to decline in cognition in older persons. J Affect Disord. 2019 05 01; 250:313-318.
    View in: PubMed
    Score: 0.037
  16. Late-life blood pressure association with cerebrovascular and Alzheimer disease pathology. Neurology. 2018 08 07; 91(6):e517-e525.
    View in: PubMed
    Score: 0.036
  17. Memory complaints, dementia, and neuropathology in older blacks and whites. Ann Neurol. 2018 04; 83(4):718-729.
    View in: PubMed
    Score: 0.035
  18. Review: Relationship of type 2 diabetes to human brain pathology. Neuropathol Appl Neurobiol. 2018 06; 44(4):347-362.
    View in: PubMed
    Score: 0.035
  19. Body Mass Index and Decline in Cognitive Function in Older Black and White Persons. J Gerontol A Biol Sci Med Sci. 2018 01 16; 73(2):198-203.
    View in: PubMed
    Score: 0.034
  20. Diabetes, Hemoglobin A1C, and Regional Alzheimer Disease and Infarct Pathology. Alzheimer Dis Assoc Disord. 2017 Jan-Mar; 31(1):41-47.
    View in: PubMed
    Score: 0.032
  21. Relation of cerebral vessel disease to Alzheimer's disease dementia and cognitive function in elderly people: a cross-sectional study. Lancet Neurol. 2016 08; 15(9):934-943.
    View in: PubMed
    Score: 0.031
  22. The Relationship of Cerebral Vessel Pathology to Brain Microinfarcts. Brain Pathol. 2017 01; 27(1):77-85.
    View in: PubMed
    Score: 0.031
  23. Diabetes is associated with cerebrovascular but not Alzheimer's disease neuropathology. Alzheimers Dement. 2016 08; 12(8):882-9.
    View in: PubMed
    Score: 0.030
  24. Association of white matter hyperintensities and gray matter volume with cognition in older individuals without cognitive impairment. Brain Struct Funct. 2016 05; 221(4):2135-46.
    View in: PubMed
    Score: 0.028
  25. Relation of antiphospholipid antibodies to postmortem brain infarcts in older people. Circulation. 2015 Jan 13; 131(2):182-9.
    View in: PubMed
    Score: 0.027
  26. Antiphospholipid antibodies, brain infarcts, and cognitive and motor decline in aging (ABICMA): design of a community-based, longitudinal, clinical-pathological study. Neuroepidemiology. 2013; 40(2):73-84.
    View in: PubMed
    Score: 0.024
  27. Microinfarct pathology, dementia, and cognitive systems. Stroke. 2011 Mar; 42(3):722-7.
    View in: PubMed
    Score: 0.021
  28. Cerebral amyloid angiopathy pathology and cognitive domains in older persons. Ann Neurol. 2011 Feb; 69(2):320-7.
    View in: PubMed
    Score: 0.021
  29. Clinical trial efforts in Alzheimer disease: why test statins? Neurology. 2010 Mar 23; 74(12):945-6.
    View in: PubMed
    Score: 0.020
  30. Diabetes and cognitive systems in older black and white persons. Alzheimer Dis Assoc Disord. 2010 Jan-Mar; 24(1):37-42.
    View in: PubMed
    Score: 0.020
  31. Update on frontotemporal dementia. Neurologist. 2010 Jan; 16(1):16-22.
    View in: PubMed
    Score: 0.020
  32. Relation of NSAIDs to incident AD, change in cognitive function, and AD pathology. Neurology. 2008 Jun 03; 70(23):2219-25.
    View in: PubMed
    Score: 0.018
  33. Statins, incident Alzheimer disease, change in cognitive function, and neuropathology. Neurology. 2008 May 06; 70(19 Pt 2):1795-802.
    View in: PubMed
    Score: 0.017
  34. Diabetes and parkinsonian signs in older persons. Alzheimer Dis Assoc Disord. 2007 Apr-Jun; 21(2):144-9.
    View in: PubMed
    Score: 0.016
  35. Clinical-pathologic study of biomarkers in FTDP-17 (PPND family with N279K tau mutation). Parkinsonism Relat Disord. 2007 May; 13(4):230-9.
    View in: PubMed
    Score: 0.016
  36. Diabetes is related to cerebral infarction but not to AD pathology in older persons. Neurology. 2006 Dec 12; 67(11):1960-5.
    View in: PubMed
    Score: 0.016
  37. Diabetes mellitus, dementia, and cognitive function in older persons. J Nutr Health Aging. 2006 Jul-Aug; 10(4):287-91.
    View in: PubMed
    Score: 0.015
  38. Diabetes and function in different cognitive systems in older individuals without dementia. Diabetes Care. 2006 Mar; 29(3):560-5.
    View in: PubMed
    Score: 0.015
  39. Glial heme oxygenase-1 expression in Alzheimer disease and mild cognitive impairment. Neurobiol Aging. 2006 Feb; 27(2):252-61.
    View in: PubMed
    Score: 0.014
  40. Diabetes mellitus and progression of rigidity and gait disturbance in older persons. Neurology. 2004 Sep 28; 63(6):996-1001.
    View in: PubMed
    Score: 0.014
  41. Diabetes mellitus and risk of Alzheimer disease and decline in cognitive function. Arch Neurol. 2004 May; 61(5):661-6.
    View in: PubMed
    Score: 0.013
  42. PETCH-DB: a Portal for?Exploring Tissue-specific and?Complex disease-associated 5-Hydroxymethylcytosines. Database (Oxford). 2023 06 10; 2023.
    View in: PubMed
    Score: 0.013
  43. Eicosanoid lipidome activation in post-mortem brain tissues of individuals with APOE4 and Alzheimer's dementia. Alzheimers Res Ther. 2022 10 11; 14(1):152.
    View in: PubMed
    Score: 0.012
  44. APOE e4 and Alzheimer's disease diagnosis associated differences in L-carnitine, GBB, TMAO, and acylcarnitines in blood and brain. Curr Res Transl Med. 2023 Jan-Mar; 71(1):103362.
    View in: PubMed
    Score: 0.012
  45. Serum creatinine levels correlate with plasma amyloid Beta protein. Alzheimer Dis Assoc Disord. 2002 Jul-Sep; 16(3):187-90.
    View in: PubMed
    Score: 0.012
  46. Calcium-dependent cytosolic phospholipase A2 activation is implicated in neuroinflammation and oxidative stress associated with ApoE4. Mol Neurodegener. 2022 06 15; 17(1):42.
    View in: PubMed
    Score: 0.012
  47. Neuroimaging and modulation in obesity and diabetes research: 10th anniversary meeting. Int J Obes (Lond). 2022 04; 46(4):718-725.
    View in: PubMed
    Score: 0.011
  48. Recent advances in the understanding of tau protein and movement disorders. Curr Opin Neurol. 2001 Aug; 14(4):491-7.
    View in: PubMed
    Score: 0.011
  49. Focal degenerative dementia syndromes. Clin Geriatr Med. 2001 May; 17(2):303-18.
    View in: PubMed
    Score: 0.011
  50. Calcium-dependent cytosolic phospholipase A2 activation is implicated in neuroinflammation and oxidative stress associated with ApoE4. Mol Neurodegener. 2021 04 16; 16(1):26.
    View in: PubMed
    Score: 0.011
  51. Late-Life Vascular Risk Score in Association With Postmortem Cerebrovascular Disease Brain Pathologies. Stroke. 2021 06; 52(6):2060-2067.
    View in: PubMed
    Score: 0.011
  52. A? (Amyloid Beta) and Tau Tangle Pathology Modifies the Association Between Small Vessel Disease and Cortical Microinfarcts. Stroke. 2021 03; 52(3):1012-1021.
    View in: PubMed
    Score: 0.011
  53. A study protocol for MindMoves: A lifestyle physical activity and cognitive training intervention to prevent cognitive impairment in older women with cardiovascular disease. Contemp Clin Trials. 2021 02; 101:106254.
    View in: PubMed
    Score: 0.011
  54. Changes in Body Mass Index Are Related to Faster Cognitive Decline Among African American Older Adults. J Am Geriatr Soc. 2020 11; 68(11):2662-2667.
    View in: PubMed
    Score: 0.010
  55. Is Midlife Metabolic Syndrome Associated With Cognitive Function Change? The Study of Women's Health Across the Nation. J Clin Endocrinol Metab. 2020 04 01; 105(4).
    View in: PubMed
    Score: 0.010
  56. Differences in the Associations Between Memory Complaints and Depressive Symptoms Among Black and White Older Adults. J Gerontol B Psychol Sci Soc Sci. 2020 03 09; 75(4):783-791.
    View in: PubMed
    Score: 0.010
  57. [Fronto-temporal dementia: a clinical approach]. Rev Neurol (Paris). 1999 Feb; 155(2):113-9.
    View in: PubMed
    Score: 0.009
  58. Vascular dysfunction-The disregarded partner of Alzheimer's disease. Alzheimers Dement. 2019 01; 15(1):158-167.
    View in: PubMed
    Score: 0.009
  59. Sex differences in Alzheimer's disease and common neuropathologies of aging. Acta Neuropathol. 2018 12; 136(6):887-900.
    View in: PubMed
    Score: 0.009
  60. Association of Financial Literacy With Hospitalization in Community-dwelling Older Adults. Med Care. 2018 07; 56(7):596-602.
    View in: PubMed
    Score: 0.009
  61. M. tuberculosis molecular variation in CNS infection: evidence for strain-dependent neurovirulence. Neurology. 1998 Jun; 50(6):1827-32.
    View in: PubMed
    Score: 0.009
  62. Watershed microinfarct pathology and cognition in older persons. Neurobiol Aging. 2018 10; 70:10-17.
    View in: PubMed
    Score: 0.009
  63. Brain insulin resistance in type 2 diabetes and Alzheimer disease: concepts and conundrums. Nat Rev Neurol. 2018 03; 14(3):168-181.
    View in: PubMed
    Score: 0.009
  64. Purpose in Life and Hospitalization for Ambulatory Care-Sensitive Conditions in Old Age. Am J Geriatr Psychiatry. 2018 03; 26(3):364-374.
    View in: PubMed
    Score: 0.008
  65. Association of Cancer History with Alzheimer's Disease Dementia and Neuropathology. J Alzheimers Dis. 2017; 56(2):699-706.
    View in: PubMed
    Score: 0.008
  66. Diabetes is Not Associated with Alzheimer's Disease Neuropathology. J Alzheimers Dis. 2017; 60(3):1035-1043.
    View in: PubMed
    Score: 0.008
  67. Cognitive decline following incident and preexisting diabetes mellitus in a population sample. Neurology. 2016 Oct 18; 87(16):1681-1687.
    View in: PubMed
    Score: 0.008
  68. Cerebrovascular and microglial states are not altered by functional neuroinflammatory gene variant. J Cereb Blood Flow Metab. 2016 Apr; 36(4):819-30.
    View in: PubMed
    Score: 0.007
  69. APOE and cerebral amyloid angiopathy in community-dwelling older persons. Neurobiol Aging. 2015 Nov; 36(11):2946-2953.
    View in: PubMed
    Score: 0.007
  70. Mixed pathology is more likely in black than white decedents with Alzheimer dementia. Neurology. 2015 Aug 11; 85(6):528-34.
    View in: PubMed
    Score: 0.007
  71. Physical activity, motor function, and white matter hyperintensity burden in healthy older adults. Neurology. 2015 Mar 31; 84(13):1294-300.
    View in: PubMed
    Score: 0.007
  72. Abnormal serine phosphorylation of insulin receptor substrate 1 is associated with tau pathology in Alzheimer's disease and tauopathies. Acta Neuropathol. 2014 Nov; 128(5):679-89.
    View in: PubMed
    Score: 0.007
  73. Astroglial heme oxygenase-1 and the origin of corpora amylacea in aging and degenerating neural tissues. Exp Neurol. 2014 Apr; 254:78-89.
    View in: PubMed
    Score: 0.007
  74. Gray-matter macrostructure in cognitively healthy older persons: associations with age and cognition. Brain Struct Funct. 2014 Nov; 219(6):2029-49.
    View in: PubMed
    Score: 0.006
  75. Apolipoprotein E and change in episodic memory in blacks and whites. Neuroepidemiology. 2013; 40(3):211-9.
    View in: PubMed
    Score: 0.006
  76. Selected findings from the Religious Orders Study and Rush Memory and Aging Project. J Alzheimers Dis. 2013; 33 Suppl 1:S397-403.
    View in: PubMed
    Score: 0.006
  77. Pathology and temporal onset of visual hallucinations, misperceptions and family misidentification distinguishes dementia with Lewy bodies from Alzheimer's disease. Parkinsonism Relat Disord. 2013 Feb; 19(2):227-31.
    View in: PubMed
    Score: 0.006
  78. Cognitive impairment, decline and fluctuations in older community-dwelling subjects with Lewy bodies. Brain. 2012 Oct; 135(Pt 10):3005-14.
    View in: PubMed
    Score: 0.006
  79. Overview and findings from the religious orders study. Curr Alzheimer Res. 2012 Jul; 9(6):628-45.
    View in: PubMed
    Score: 0.006
  80. Demonstrated brain insulin resistance in Alzheimer's disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline. J Clin Invest. 2012 Apr; 122(4):1316-38.
    View in: PubMed
    Score: 0.006
  81. Parkinsonian signs and incident falls in older persons without Parkinson's disease. J Am Geriatr Soc. 2010 Jan; 58(1):205-6.
    View in: PubMed
    Score: 0.005
  82. The neuropathology of probable Alzheimer disease and mild cognitive impairment. Ann Neurol. 2009 Aug; 66(2):200-8.
    View in: PubMed
    Score: 0.005
  83. Brain sterol dysregulation in sporadic AD and MCI: relationship to heme oxygenase-1. J Neurochem. 2009 Aug; 110(4):1241-53.
    View in: PubMed
    Score: 0.005
  84. Lower extremity motor function and disability in mild cognitive impairment. Exp Aging Res. 2007 Jul-Sep; 33(3):355-71.
    View in: PubMed
    Score: 0.004
  85. Subcortical infarcts, Alzheimer's disease pathology, and memory function in older persons. Ann Neurol. 2007 Jul; 62(1):59-66.
    View in: PubMed
    Score: 0.004
  86. Mixed brain pathologies account for most dementia cases in community-dwelling older persons. Neurology. 2007 Dec 11; 69(24):2197-204.
    View in: PubMed
    Score: 0.004
  87. Brain erythropoietin receptor expression in Alzheimer disease and mild cognitive impairment. J Neuropathol Exp Neurol. 2007 May; 66(5):389-98.
    View in: PubMed
    Score: 0.004
  88. Decision rules guiding the clinical diagnosis of Alzheimer's disease in two community-based cohort studies compared to standard practice in a clinic-based cohort study. Neuroepidemiology. 2006; 27(3):169-76.
    View in: PubMed
    Score: 0.004
  89. Blood pressure and lower limb function in older persons. J Gerontol A Biol Sci Med Sci. 2006 Aug; 61(8):839-43.
    View in: PubMed
    Score: 0.004
  90. Neuropathology of older persons without cognitive impairment from two community-based studies. Neurology. 2006 Jun 27; 66(12):1837-44.
    View in: PubMed
    Score: 0.004
  91. Family history of dementia is a risk factor for Lewy body disease. Neurology. 2006 Jun 27; 66(12):1949-50.
    View in: PubMed
    Score: 0.004
  92. Parkinsonian signs in subjects with mild cognitive impairment. Neurology. 2005 Dec 27; 65(12):1901-6.
    View in: PubMed
    Score: 0.004
  93. Relation of blood pressure to risk of incident Alzheimer's disease and change in global cognitive function in older persons. Neuroepidemiology. 2006; 26(1):30-6.
    View in: PubMed
    Score: 0.004
  94. Dementia with Lewy bodies: current concepts. Dement Geriatr Cogn Disord. 2005; 20(5):306-20.
    View in: PubMed
    Score: 0.004
  95. Different patterns of magnetic resonance imaging atrophy for frontotemporal lobar degeneration syndromes. Arch Neurol. 2005 Jul; 62(7):1106-10.
    View in: PubMed
    Score: 0.004
  96. Early and pre-symptomatic neuropsychological dysfunction in the PPND family with the N279K tau mutation. Parkinsonism Relat Disord. 2003 Jun; 9(5):265-70.
    View in: PubMed
    Score: 0.003
  97. Similar subcortical pattern of cognitive impairment in AIDS patients with and without dementia. Eur J Neurol. 2000 Mar; 7(2):151-8.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.